tirzepatide and semaglutide peptide or small molecule vs Tirzepatide: Complete Comparison (2026) Comparing Tirzepatide vs Semaglutide: Effects,
Description
Common side effects reported in clinical trials include: Gastrointestinal disturbances : cramping, diarrhoea, flatulence, constipation, and abdominal discomfort are the most frequently reported adverse effects, occurring in up to 30% of users in some studies Nausea : particularly when starting treatment or taking higher doses These effects are typically mild to moderate and often improve with continued use or dose reduction Less common but important considerations : Berberine may cause a temporary increase in bilirubin levels, which could be problematic in individuals with liver disease Berberine should not be used during pregnancy or breastfeeding due to potential risks to the foetus or infant (including theoretical risk of kernicterus in infants) Berberine is not recommended for use in children or adolescents Allergic reactions, whilst rare, can occur Significant drug interactions are a major concern: Diabetes medications : Berberine may have additive glucose-lowering effects, particularly with insulin and sulphonylureas, increasing the risk of hypoglycaemia

Semaglutide, available under the brand names Ozempic and Wegovy, enhances these effects by promoting insulin production and reducing glucagon levels

Mol Metab (2021) 47:101180

After incubation overnight at 4 C with primary antibodies diluted in 5% BSA, the sections were treated with fluorophore-conjugated secondary antibodies (Alexa Fluor 488, 594, or 647

The standard injection schedule reaches a target maintenance dose of 2.4 mg after approximately 16 weeks

Boost your fiber intake with unsweetened oatmeal and berries at breakfast, a salad with beans and nuts at lunch, and roasted vegetables and quinoa at dinner
